WC
GCVRZ

Whitney & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Whitney & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-31,885
Closed -$4K – 109
2015
Q4 		$4K Sell
31,885
-100
-0.3% -$14 ﹤0.01% 110
2015
Q3 		$6K Hold
31,985
– – ﹤0.01% 106
2015
Q2 		$22K Buy
+31,985
New +$22.1K 0.01% 103

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Whitney & Co's GCVRZ Position: Q1 2016 in Review

Whitney & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2016, closing a stake of 31,885 shares — an estimated $4K sold.

Whitney & Co first reported a position in GCVRZ in Q2 2015 and held it in 3 quarters. The position peaked at $22K in Q2 2015. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2016.

  • Whitney & Co reported no remaining Sanofi Contingent Value Rights position as of Q1 2016 after selling out during the quarter.
  • Whitney & Co sold 31,885 Sanofi Contingent Value Rights shares in Q1 2016, an estimated $4K.
  • Whitney & Co first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 3 quarters.
  • Whitney & Co's Sanofi Contingent Value Rights position peaked at $22K in Q2 2015.
  • 106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2016.

Based on Whitney & Co's 13F filing for Q1 2016, filed 14 Apr 2016.